PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.71%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-9.27%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-8.18%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-8.18%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-20.38%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-20.51%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-19.61%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.38%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.73%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
0.69%
Positive OCF growth while META is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-17.42%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
529.66%
10Y revenue/share CAGR under 50% of META's 1969.67%. Michael Burry would suspect a lasting competitive disadvantage.
187.72%
5Y revenue/share CAGR at 50-75% of META's 274.77%. Martin Whitman would worry about a lagging mid-term growth trajectory.
97.00%
3Y revenue/share CAGR similar to META's 94.11%. Walter Schloss would assume both companies experience comparable short-term cycles.
569.81%
10Y OCF/share CAGR under 50% of META's 2404.37%. Michael Burry would worry about a persistent underperformance in cash creation.
175.32%
5Y OCF/share CAGR at 75-90% of META's 200.17%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
120.22%
3Y OCF/share CAGR above 1.5x META's 58.59%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
460.49%
Below 50% of META's 2757.16%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
217.16%
5Y net income/share CAGR 1.25-1.5x META's 163.22%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
159.89%
3Y net income/share CAGR 50-75% of META's 222.29%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
305.64%
Below 50% of META's 1627.48%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
83.48%
5Y equity/share CAGR at 50-75% of META's 113.73%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
45.73%
3Y equity/share CAGR similar to META's 49.37%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.37%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
17.01%
Inventory growth of 17.01% while META is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-0.60%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.33%
Similar to META's 1.29%. Walter Schloss finds parallel capital usage or profit distribution strategies.
8.45%
Debt growth far above META's 1.30%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.72%
R&D growth drastically higher vs. META's 9.38%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-21.67%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.